Indiana just joined West Virginia and Arkansas in delivering an important win for Hoosiers who are struggling to afford their medicines. This week, Governor Holcomb signed into law Senate Bill 8 recently passed by the Indiana legislature. This new law will ensure that Indiana patients aren’t paying more for their medicines than their health insurance company or the middlemen known as pharmacy benefit managers (PBMs).
This concept, known as “share the savings,” puts money back in patients’ pockets by requiring insurers and the PBMs they work with to share the rebates, discounts, and other price concessions they receive from manufacturers directly with patients at the pharmacy counter.
Negotiations between pharmaceutical companies, health insurers, PBMs and others result in significant rebates and discounts that totaled $236 billion in 2021. However, those savings aren’t always shared with patients, which means there are patients who end up paying more for their medicine than their insurer and PBM. This legislation requires 85% of the rebates health insurance companies receive from manufacturers be applied to lower drug costs for patients at the pharmacy counter in Indiana’s individual market and requires insurers to pass through 100% of rebates to plan sponsors (employers) in the fully insured group market, which employers can decide how to share with enrollees. This means lower out-of-pocket costs for Hoosiers, as well as an increased likelihood of better health outcomes as more people will take their medicine as prescribed.
A recent 50-state poll conducted by Morning Consult on behalf of PhRMA found that strong majorities in every state, including Indiana, agree lowering out-of-pocket costs for health care should be a top policy priority. Specifically:
• 80% of adults in Indiana support a law that would prevent patients from paying more for their prescription medicine than their insurance company or pharmacy benefit manager (PBM).
• 82% of respondents in Indiana agreed elected officials should ensure health insurance companies and middlemen are held accountable for their role in keeping patients from the medicines they need.
Indiana patients should have access to affordable medicines, and this legislation is a significant step toward achieving that goal.
To learn more, visit PhRMA.org/States.
Reid Porter
Reid Porter is senior director of public affairs at PhRMA, where he focuses on key policy priorities, member engagement and state media relations. He brings over two decades of experience leading communications and managing complex issues across the biopharmaceutical, technology and energy sectors. Porter holds a B.A. from Middlebury College, where he double‑majored in English and Spanish, and a graduate certificate in Publishing from Columbia University. Outside of work, he enjoys writing, traveling, cheering for the Green Bay Packers, playing and watching soccer, playing the violin, rereading Hemingway novels and spending time with family.
Insurers are blaming medicines for premium hikes in Massachusetts. The state's own data suggests otherwise.
340B is growing, but it is unclear if Illinois patients benefit
State price-setting boards create more questions than answers
States should avoid repeating the IRA’s price‑setting mistakes
Virginia should be cautious about importing federal price-setting mechanisms
New report from Minnesota: 340B is generating billions for big hospitals
50-state poll says Americans are concerned that hospital markups hurt patients
California’s landmark PBM crackdown: A wake-up call for reform
Why states struggle to deliver savings: Middlemen and 340B siphon dollars from patients and states
Medical innovation takes center stage in state legislatures
North Carolina puts patients first with rebate pass-through law
How the 340B hospital markup program could hurt Michigan patients
Virginia, Don't Let Politicians Take Away Your Medicine
7 reasons why states shouldn’t copy the IRA’s price setting mistake
Three ways state drug price setting boards fail patients
Biopharmaceutical industry supports jobs and drives economic growth across the United States
Government price-setting boards: Why Minnesota needs to take a better approach
Insurance data: PBM reform has no material impact on premiums
Government price setting won’t help patients in Illinois
Colorado is proof: Too many unanswered questions remain about state government price setting's impact on patients and providers
The truth about Nebraska's price setting push
ICYMI: Scott LaGanga and Matt Salo deliver a State of the Industry Report
4 truths about state government price setting
Three concerns about Colorado's approach to government price setting
Michigan proposal jeopardizes access to medicines
A win for Indiana patients: “Sharing the savings” legislation now law
State Policy
share the savings
A win for Indiana patients: “Sharing the savings” legislation now law
A win for Indiana patients: “Sharing the savings” legislation now law